Simplex Trading
EWTX icon

Simplex Trading’s Edgewise Therapeutics EWTX Stock Holding History

Simplex Trading’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.7K Sell
1,832
-7,237
-80% -$209K ﹤0.01% 5717
2025
Q4 		$225K Buy
9,069
+1,479
+19% +$29.7K ﹤0.01% 4107
2025
Q3 		$123K Buy
7,590
+3,407
+81% +$48.3K ﹤0.01% 5510
2025
Q2 		$54K Buy
+4,183
New +$60.3K ﹤0.01% 5851
2025
Q1 		– Sell
-50,130
Closed -$1.32M – 8790
2024
Q4 		$1.34M Sell
50,130
-23,900
-32% -$761K ﹤0.01% 2563
2024
Q3 		$1.98M Buy
74,030
+71,296
+2,608% +$1.42M ﹤0.01% 2286
2024
Q2 		$49K Sell
2,734
-291
-10% -$5.08K ﹤0.01% 6106
2024
Q1 		$55K Buy
+3,025
New +$48.1K ﹤0.01% 6177
2023
Q4 		– Sell
-371
Closed -$2.6K – 9060
2023
Q3 		$2K Sell
371
-2,158
-85% -$14.7K ﹤0.01% 8080
2023
Q2 		$19K Sell
2,529
-446
-15% -$3.76K ﹤0.01% 6822
2023
Q1 		$19K Buy
+2,975
New +$27.6K ﹤0.01% 6957

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Simplex Trading's EWTX Position: Q1 2026 in Review

Simplex Trading reduced its Edgewise Therapeutics (EWTX) stake by 80% in Q1 2026, selling an estimated $209K and leaving 1,832 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5717.

Simplex Trading first reported a position in EWTX in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.98M in Q3 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Simplex Trading held 1,832 shares of Edgewise Therapeutics worth $57.7K as of Q1 2026.
  • Simplex Trading sold 7,237 Edgewise Therapeutics shares in Q1 2026, an estimated $209K.
  • Edgewise Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5717 holding.
  • Simplex Trading first reported a position in Edgewise Therapeutics in Q1 2023 and has held it in 11 quarters since.
  • Simplex Trading's Edgewise Therapeutics position peaked at $1.98M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.